Financials ORPEA

Equities

ORP

FR001400NLM4

Healthcare Facilities & Services

Market Closed - Euronext Paris 11:35:14 2024-04-26 am EDT 5-day change 1st Jan Change
12.8 EUR +7.29% Intraday chart for ORPEA +4.49% -24.26%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 5,760 7,380 6,946 5,691 398.9 2,038 2,038 -
Enterprise Value (EV) 1 10,782 14,710 15,239 16,866 12,926 2,195 8,639 7,450
P/E ratio 26.2 x 32.7 x 44.1 x 87.2 x -0.1 x -0 x -0.01 x -0.02 x
Yield 1.34% 1.14% 0.84% - - - - -
Capitalization / Revenue 1.68 x 1.97 x 1.77 x 1.33 x 0.09 x 0.42 x 0.37 x 0.34 x
EV / Revenue 3.15 x 3.93 x 3.89 x 3.94 x 2.76 x 0.42 x 1.59 x 1.25 x
EV / EBITDA 17.9 x 15.5 x 16.4 x 16.3 x 17.1 x 12.8 x 9.66 x 7.66 x
EV / FCF -19.8 x -70 x -72.2 x 32.6 x 51.5 x -65.6 x 23.7 x 14.3 x
FCF Yield -5.05% -1.43% -1.38% 3.07% 1.94% -1.52% 4.23% 6.97%
Price to Book 1.94 x 2.45 x 1.99 x 1.5 x -0.27 x 0 x 0 x 0 x
Nbr of stocks (in thousands) 64.6 64.6 64.6 64.6 64.6 159,192 159,192 -
Reference price 2 89,220 114,300 107,550 88,100 6,172 12.80 12.80 12.80
Announcement Date 3/26/19 3/17/20 3/16/21 3/11/22 5/12/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3,420 3,740 3,922 4,285 4,681 5,198 5,438 5,971
EBITDA 1 604 949.4 926.5 1,037 756 750.2 894.5 972.2
EBIT 1 427.7 503.7 422.9 395.7 -49 -112 -6.8 100.9
Operating Margin 12.51% 13.47% 10.78% 9.24% -1.05% -2.22% -0.13% 1.69%
Earnings before Tax (EBT) 1 309.4 325.7 210.3 105.8 -4,591 -83 -30 -
Net income 1 220.4 233.8 160 65.18 -4,027 -457.2 -202.4 -94.85
Net margin 6.44% 6.25% 4.08% 1.52% -86.03% -9.05% -3.72% -1.59%
EPS 2 3,410 3,492 2,440 1,010 -62,330 -14,065 -1,350 -630.0
Free Cash Flow 1 -544 -210 -211 517 251 -145.9 365.2 519.5
FCF margin -15.91% -5.61% -5.38% 12.06% 5.36% -2.89% 6.72% 8.7%
FCF Conversion (EBITDA) - - - 49.85% 33.2% - 40.83% 53.44%
FCF Conversion (Net income) - - - 793.1% - - - -
Dividend per Share 2 1,200 1,300 900.0 - - - - -
Announcement Date 3/26/19 3/17/20 3/16/21 3/11/22 5/12/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2020 S1 2020 S2 2021 Q1 2021 Q2 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 1,840 1,904 2,018 1,027 1,042 2,069 1,110 1,148 1,192 2,312 1,181 1,234 1,305
EBITDA 317.6 - - - - - - - - - - - -
EBIT - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - -
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 9/24/19 7/21/20 3/16/21 6/3/21 7/20/21 7/20/21 11/3/21 5/5/22 7/20/22 7/20/22 11/8/22 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 5,022 7,330 8,293 11,175 12,527 7,538 6,601 5,412
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 8.315 x 7.721 x 8.951 x 10.78 x 16.57 x 10.05 x 7.379 x 5.567 x
Free Cash Flow 1 -544 -210 -211 517 251 -146 365 520
ROE (net income / shareholders' equity) 7.75% 7.8% 5.01% 1.79% - -15.8% -9.35% -3.65%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 45,974 46,678 54,090 58,825 -23,236 23,150 13,275 12,680
Cash Flow per Share 2 6,426 6,586 11,382 11,679 6,342 267.0 309.0 -
Capex 1 718 651 915 1,271 159 182 198 210
Capex / Sales 21% 17.41% 23.33% 29.66% 3.39% 3.6% 3.65% 3.52%
Announcement Date 3/26/19 3/17/20 3/16/21 3/11/22 5/12/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.8 EUR
Average target price
10,975 EUR
Spread / Average Target
+85,642.19%
Consensus

Quarterly revenue - Rate of surprise